FindTrial
Sign In

Multimodal pain management after spinal surgery for pediatric and adolescent spinal malformation

Multimodal pain management after spinal surgery for pediatric and adolescent spinal malformation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018594
Enrollment
Unknown
Registered
2018-09-26
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric and adolescent spinal malformation

Interventions

A:Gabapentin (5mg/kg, qd, po, max 300mg) at 1 hour before skin incision, and ibuprofen (10mg/kg, q6h, po, max 400mg), gabapentin (5mg/kg, tid, po, max 300mg) and postoperative patient-controlled anal
B:Postoperative fentanyl intravenous patient-controlled analgesia only. Pethidine(50mg, im) is applied when acute pain breaks out.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients under 18 years old with spinal malformation including idiopathic scoliosiscongenital soliosis and spinal kyphosis; 2. Patients requires corrective surgery.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale(VAS) at 24h, 48h, 72h, 96h after operation;fentanyl consumption consumption at all the evaluation time points;pethidine consumption at all the evaluation time points;length of hospital stay;time interval at postoperative first walk;side effects, including nausea, vomiting and pruritus;—

Countries

China

Contacts

Public ContactYueming Song

West China Hospital, Sichuan University

543109217@qq.com+86 18980601382

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026